-
Eli Lilly closes Dermira plant to transfer hyperhidrosis drug Qbrexza
Time of Update: 2021-05-10
CompilationFan DongdongA few days ago, Eli Lilly announced that it would close its Dermira plant in Menlo Park, lay off 163 employees, and intend to sell the hyperhidrosis drug Qbrexza to Journey Medical.
-
Intensive anti-corruption efforts in the pharmaceutical field make new cuts to falsely high drug prices
Time of Update: 2021-05-10
The "two-invoice system" for the purchase and sale of medicines makes intermediate price increases impossible and can cut the middle chain of medicine corruption.
If the two incidents are linked together, it shows that the intensity of punishment of medical corruption is increasing and the means are more abundant.
-
What is the salary gap between multinational pharmaceutical companies and local pharmaceutical companies?
Time of Update: 2021-05-10
According to statistics from the Korean Financial Supervisory Commission (FSS), the average annual salary of the management and employees of multinational pharmaceutical companies in South Korea was 91 million won (about 530,000 yuan) last year.
-
Yu Jinyi appointed as Chief Business Officer of Sanofi Pasteur China
Time of Update: 2021-05-10
On the morning of the 16th, Zhang Heping, general manager of Sanofi Pasteur China, announced to employees that from April 19, Yu Jinyi will join Sanofi Pasteur China as the Chief Business Officer (CBO) and become Sanofi Bar A member of the Steward China Management Committee, reports directly to Zhang Heping, and works in Beijing.
-
Yangzijiang Pharmaceutical was fined 764 million yuan for implementing a monopoly agreement
Time of Update: 2021-05-10
The above actions of Yangtze River Pharmaceutical Group have eliminated and restricted competition, harmed the legitimate rights and interests of consumers and the public interest, and violated Article 14 of the Anti-Monopoly Law, which prohibits operators and counterparties from reaching the following monopoly agreements: (1) Fixed The price for resale of commodities to a third party; (2) The provisions of limiting the minimum price for resale of commodities to a third party.
-
Back to the downturn?
Time of Update: 2021-05-10
In the second half of last year, biopharmaceutical M&A activities revived, including several large acquisitions, such as AstraZeneca’s acquisition of Alexion, and Gilead Sciences’ $21 billion acquisition of Immunomedics.
-
Puli Pharmaceutical 500mg Levofloxacin Tablets Obtained Drug Registration Approval
Time of Update: 2021-05-10
Because of its strong antibacterial effect, broad antibacterial spectrum, and a positive antibacterial effect, it is currently the first-line clinical anti-infection drug.
Zhejiang Puli's levofloxacin tablets have been submitted for registration in the European Union (Netherlands and Germany) and China after the start of research and development.
-
A number of machinery companies announced their performance: Johnson & Johnson, Abbott, GE...
Time of Update: 2021-05-09
847 billion, and medical business revenue was US$4.
847 billion, and medical business revenue was US$4.
847 billion, and medical business revenue was US$4.
477 billion euros, and the transportation business revenue is 2.
477 billion euros, and the transportation business revenue is 2.
-
Involving more than 300 million insured persons, what are the key points of this medical insurance reform?
Time of Update: 2021-05-09
A few days ago, the General Office of the State Council issued the "Guiding Opinions on Establishing and Improving the Employee Basic Medical Insurance Outpatient Mutual Aid Guarantee Mechanism".
-
FDA accelerates approval of the first CD19-targeted antibody conjugate drug has been clinically approved in China
Time of Update: 2021-05-09
Today, ADC Therapeutics announced that the US FDA has accelerated the approval of the CD19-targeting antibody conjugate Zynlonta (loncastuximabtesirine-lpyl) as a single-drug treatment for adult patients with relapsed/refractory large B-cell lymphoma, these patients have at least received Two systemic therapies.
-
376 medicines can't be sold in a batch of hospitals
Time of Update: 2021-05-09
A large number of varieties need to be removed from the networkOn April 25, the Henan Provincial Public Resources Trading Center issued the "Notice on Publicizing the Evaluation Results of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Non-selected Drugs" (hereinafter referred to as the "Notice").
-
This is the fifth batch of nationally-sourced drugs catalogues!
Time of Update: 2021-05-09
In addition to Shanxi Province, the Sichuan Pharmaceutical Procurement Center today also issued the "Notice on Filling in the Purchasing Data of the Fifth Batch of Nationally Organized Drug Centralized Procurement Varieties" (Chuan Yao Zhao [2021] No.
-
Results of two Phase III studies of Bristol-Myers Squibb's oral TYK-2 inhibitor announced (with PPT)
Time of Update: 2021-05-09
The main common endpoints of the two studies were compared with placebo, reaching PASI 75 (psoriasis area and severity index score improvement of 75%) and sPGA 0/1 (doctors overall assessment of skin symptoms were completely cleared/ Almost completely cleared) the proportion of subjects.
-
The traditional Chinese medicine Lianhua Qingwen has these characteristics in treating colds
Time of Update: 2021-05-09
The prescription of the traditional Chinese medicine Lianhua Qingwen covers Xinliangtou Biao, lungs and heat release, cough and asthma, and heat-clearing and detoxification drugs, which can treat the symptoms of the common cold comprehensively.
-
Hengrui Pharmaceutical's independent director Li Yuanchao resigns after his term of office expires
Time of Update: 2021-05-09
On April 19, Hengrui Pharmaceutical issued an announcement stating that according to the "Guiding Opinions on Establishing Independent Director System in Listed Companies", "Articles of Association of Jiangsu Hengrui Pharmaceutical Co.
-
A well-known pharmaceutical company abolished its sales team
Time of Update: 2021-05-09
As for the reasons for the layoffs, one or two can be seen from the previous list of the fourth batch of centralized procurement-Propofol medium/long-chain fat emulsion injection, which accounts for 61.
-
Hausen's smoking cessation drug "Varenicline tartrate tablets" was approved for listing
Time of Update: 2021-05-09
The results of the study showed that varenicline does not increase the risk of negative neuropsychiatric events for smokers who have no history of mental disorders, and that varenicline is significantly more effective than nicotine transdermal patches and bupropion.
-
What is the salary of the CEO of the world's top 20 pharmaceutical giants by market value?
Time of Update: 2021-05-09
If bonuses and stock options are also taken into account, the annual salary of the CEOs of pharmaceutical giants can generally reach tens of millions of dollars, such as Pfizer's Albert Bourla and Johnson & Johnson's Alex Gorsky and Pascal Soriot of AstraZeneca.
-
Hospitals and pharmacies competing for drug revenue will become a long-term trend
Time of Update: 2021-05-09
However, the core demand of the hospital is to keep the income from expensive drugs in the hospital, which is in conflict with the PBM and insurance companies that own a large number of specialty drug pharmacies.
-
New cephalosporin drug, cefoperazone sodium and tazobactam sodium (6:1) for injection was approved for marketing
Time of Update: 2021-05-09
Table 3: TOP10 varieties of cephalosporin injection in 2020Source: The terminal competition pattern of public hospitals in key provinces and cities of MeinenetNote: * is the product planned to participate in the fifth batch of national sourcingThere are two compound preparations in the TOP10 injection varieties, but their fates are different.
